- Home
- UVE vs DNTH Comparison
UVE vs DNTH Comparison
Compare UVE & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UVE
- DNTH
- Stock Information
- Founded
- UVE 1990
- DNTH 2015
- Country
- UVE United States
- DNTH United States
- Employees
- UVE N/A
- DNTH N/A
- Industry
- UVE Property-Casualty Insurers
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- UVE Finance
- DNTH Health Care
- Exchange
- UVE Nasdaq
- DNTH Nasdaq
- Market Cap
- UVE 642.7M
- DNTH 724.8M
- IPO Year
- UVE 1992
- DNTH N/A
- Fundamental
- Price
- UVE $24.08
- DNTH $16.83
- Analyst Decision
- UVE Buy
- DNTH Strong Buy
- Analyst Count
- UVE 1
- DNTH 8
- Target Price
- UVE $25.00
- DNTH $54.33
- AVG Volume (30 Days)
- UVE 186.6K
- DNTH 363.8K
- Earning Date
- UVE 04-24-2025
- DNTH 03-11-2025
- Dividend Yield
- UVE 3.19%
- DNTH N/A
- EPS Growth
- UVE N/A
- DNTH N/A
- EPS
- UVE 2.01
- DNTH N/A
- Revenue
- UVE $1,520,536,000.00
- DNTH $6,235,000.00
- Revenue This Year
- UVE N/A
- DNTH N/A
- Revenue Next Year
- UVE $3.77
- DNTH N/A
- P/E Ratio
- UVE $12.00
- DNTH N/A
- Revenue Growth
- UVE 9.27
- DNTH 120.63
- 52 Week Low
- UVE $16.50
- DNTH $16.44
- 52 Week High
- UVE $24.14
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- UVE 74.18
- DNTH 32.72
- Support Level
- UVE $21.23
- DNTH $17.50
- Resistance Level
- UVE $21.95
- DNTH $20.45
- Average True Range (ATR)
- UVE 0.66
- DNTH 1.65
- MACD
- UVE 0.21
- DNTH -0.31
- Stochastic Oscillator
- UVE 98.43
- DNTH 6.36
About UVE UNIVERSAL INSURANCE HOLDINGS INC
Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums. It operates within Florida and across the United States. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.